Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 5/2015

01-10-2015 | Review Article

Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data

Authors: Tracey-Lea Laba, Beverley Essue, Merel Kimman, Stephen Jan

Published in: The Patient - Patient-Centered Outcomes Research | Issue 5/2015

Login to get access

Abstract

Nonadherence is a global problem undermining the cost-effectiveness of evidence-based medications. Aligning treatment choices with patient preferences may promote adherent behaviour: eliciting patient treatment preferences may help resolve the problem of nonadherence. As there is no reliable measure of nonadherent behaviour that can be used to derive preferences, stated-preference techniques offer a robust alternative. To understand patient preferences in medication nonadherence, we systematically appraised full-text English studies (from database inception to 24 February 2014) involving participants evaluating hypothetical scenarios to elicit preferences as an explicit means to understand medication nonadherence. Study characteristics (e.g. setting, disease, stated-preference method), attribute type and influence on choice were extracted. Seventeen full-text articles (4,456 patients) were included in the review, which reports stated-preference elicitation studies across a wide range of chronic and acute conditions. All studies were conducted in high-income settings. The influence of drug-related factors was predominant in patients’ preferences for treatment. Patients preferred efficacious over safe medications except when considering the duration of therapy, but dosing and cost appeared more important when contemplating adherence. Patient characteristics, particularly medication experience, significantly influenced preferences. A disparity between stated preferences for treatment and adherence was reported. When using stated-preference techniques to understand nonadherence, this manuscript highlights that there is much room for methodological development. Studies outside of high-income settings are needed, particularly in relation to chronic diseases, for which nonadherence poses a substantial economic burden to health systems and patients. To inform the problem of sustaining adherence, prospective research is needed to understand how preferences change with time. The usefulness of stated-preference techniques to inform policy and practice requires a better understanding of how stated preferences relate to actual adherence behaviour.
Appendix
Available only for authorised users
Literature
1.
go back to reference Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, adherence and compliance in medicine taking. London: National Co-ordinating Centre for NHS Delivery and Organisation R & D (NCCSDO), London School of Hygiene and Tropical Medicine; 2005. Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, adherence and compliance in medicine taking. London: National Co-ordinating Centre for NHS Delivery and Organisation R & D (NCCSDO), London School of Hygiene and Tropical Medicine; 2005.
2.
go back to reference Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (update of Cochrane Database Syst Rev. 2005;(4):CD000011; PMID: 16235271). Cochrane Database Syst Rev. 2008;2:CD000011. doi:10.1002/14651858.CD000011.pub3.PubMed Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (update of Cochrane Database Syst Rev. 2005;(4):CD000011; PMID: 16235271). Cochrane Database Syst Rev. 2008;2:CD000011. doi:10.​1002/​14651858.​CD000011.​pub3.PubMed
4.
go back to reference Daleboudt GMN, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res. 2011;63(3):342–50. doi:10.1002/acr.20411. Daleboudt GMN, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res. 2011;63(3):342–50. doi:10.​1002/​acr.​20411.
6.
go back to reference Goren A, Gupta S, Dibonaventura MD. Demographic and health characteristics associated with intentional and unintentional non-adherence among costly chronic conditions in the United States. Value Health. 2012;15(4):A197. doi:10.1016/j.jval.2012.03.1064.CrossRef Goren A, Gupta S, Dibonaventura MD. Demographic and health characteristics associated with intentional and unintentional non-adherence among costly chronic conditions in the United States. Value Health. 2012;15(4):A197. doi:10.​1016/​j.​jval.​2012.​03.​1064.CrossRef
9.
go back to reference Lindquist L, Go L, Jain N, Baker D. Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge instructions. J Gen Intern Med. 2010;25:S382–3. doi:10.1007/s11606-011-1886-3.CrossRef Lindquist L, Go L, Jain N, Baker D. Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge instructions. J Gen Intern Med. 2010;25:S382–3. doi:10.​1007/​s11606-011-1886-3.CrossRef
11.
go back to reference Norton WE, Amico KR, Fisher WA, Shuper PA, Ferrer RA, Cornman DH, et al. Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care. AIDS Care. 2010;22(8):979–87. doi:10.1080/09540121003758630.PubMedCentralCrossRefPubMed Norton WE, Amico KR, Fisher WA, Shuper PA, Ferrer RA, Cornman DH, et al. Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care. AIDS Care. 2010;22(8):979–87. doi:10.​1080/​0954012100375863​0.PubMedCentralCrossRefPubMed
12.
go back to reference Radcliffe EJ, Morgan M, Wolfe C. Medicines knowledge, concerns and needs among stroke patients aged 75 years and over compared with patients with other chronic conditions. Cerebrovasc Dis. 2010;29:326. doi:10.1159/000321266. Radcliffe EJ, Morgan M, Wolfe C. Medicines knowledge, concerns and needs among stroke patients aged 75 years and over compared with patients with other chronic conditions. Cerebrovasc Dis. 2010;29:326. doi:10.​1159/​000321266.
13.
go back to reference Stack RJ, Bundy CE, Eliott RA, New JP, Gibson M, Noyce PR. Intentional and unintentional non-adherence in community dwelling people with type 2 diabetes: the effect of varying numbers of medicines. Br J Diabetes Vasc Dis. 2010;10(3):148–52. doi:10.1177/1474651409357034.CrossRef Stack RJ, Bundy CE, Eliott RA, New JP, Gibson M, Noyce PR. Intentional and unintentional non-adherence in community dwelling people with type 2 diabetes: the effect of varying numbers of medicines. Br J Diabetes Vasc Dis. 2010;10(3):148–52. doi:10.​1177/​1474651409357034​.CrossRef
16.
go back to reference Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004–2006. Med J Aust. 2008;188(4):224–7.PubMed Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004–2006. Med J Aust. 2008;188(4):224–7.PubMed
17.
go back to reference Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728–40.PubMed Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728–40.PubMed
19.
go back to reference Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313–56.CrossRefPubMed Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313–56.CrossRefPubMed
22.
go back to reference Parashar S, Palmer AK, O’Brien N, Chan K, Shen A, Coulter S, et al. Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed. AIDS Behav. 2011;15(8):1612–22. doi:10.1007/s10461-011-0026-8.CrossRefPubMed Parashar S, Palmer AK, O’Brien N, Chan K, Shen A, Coulter S, et al. Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed. AIDS Behav. 2011;15(8):1612–22. doi:10.​1007/​s10461-011-0026-8.CrossRefPubMed
26.
go back to reference DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMed DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMed
31.
go back to reference Dilokthornsakul P, Chaiyakunapruk N, Nimpitakpong P, Jeanpeerapong N, Sruamsiri R. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure. Value Health. 2012;15(1 Suppl):S9–14. doi:10.1016/j.jval.2011.11.019.CrossRefPubMed Dilokthornsakul P, Chaiyakunapruk N, Nimpitakpong P, Jeanpeerapong N, Sruamsiri R. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure. Value Health. 2012;15(1 Suppl):S9–14. doi:10.​1016/​j.​jval.​2011.​11.​019.CrossRefPubMed
32.
34.
go back to reference Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff. 2012;31(8):1836–46. doi:10.1377/hlthaff.2011.1198.CrossRef Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff. 2012;31(8):1836–46. doi:10.​1377/​hlthaff.​2011.​1198.CrossRef
35.
go back to reference Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13. doi:10.1016/j.jval.2010.11.013. Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13. doi:10.​1016/​j.​jval.​2010.​11.​013.
36.
go back to reference Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–77.CrossRefPubMed Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–77.CrossRefPubMed
38.
go back to reference Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care. 1999;15(3):443–57.PubMed Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care. 1999;15(3):443–57.PubMed
39.
go back to reference Marshall D, Bridges JFP, Hauber B, Cameron R, Donnalley L, Fyie K, et al. Conjoint analysis applications in health––how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient Patient Cent Outcomes Res. 2010;3(4):249–56. doi:10.2165/11539650-000000000-00000.CrossRef Marshall D, Bridges JFP, Hauber B, Cameron R, Donnalley L, Fyie K, et al. Conjoint analysis applications in health––how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient Patient Cent Outcomes Res. 2010;3(4):249–56. doi:10.​2165/​11539650-000000000-00000.CrossRef
45.
go back to reference King MT, Hall J, Lancsar E, Fiebig D, Hossain I, Louviere J, et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ. 2007;16(7):703–17. doi:10.1002/hec.1193.CrossRefPubMed King MT, Hall J, Lancsar E, Fiebig D, Hossain I, Louviere J, et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ. 2007;16(7):703–17. doi:10.​1002/​hec.​1193.CrossRefPubMed
49.
go back to reference Mahadevia PJ, Shah S, Leibman C, Kleinman L, O’Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2004;93(4):345–50. doi:10.1016/S1081-1206(10)61393-2.CrossRefPubMed Mahadevia PJ, Shah S, Leibman C, Kleinman L, O’Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2004;93(4):345–50. doi:10.​1016/​S1081-1206(10)61393-2.CrossRefPubMed
52.
go back to reference Schackman BR, Teixeira PA, Weitzman G, Mushlin AI, Jacobson IM. Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree? Med Decis Mak. 2008;28(2):233–42. doi:10.1177/0272989X07311753.CrossRef Schackman BR, Teixeira PA, Weitzman G, Mushlin AI, Jacobson IM. Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree? Med Decis Mak. 2008;28(2):233–42. doi:10.​1177/​0272989X07311753​.CrossRef
54.
go back to reference Brett Hauber A, Gonzalez JM, Coombs J, Sirulnik A, Palacios D, Scherzer N. Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST). Patient Prefer Adher. 2011;5:307–14. doi:10.2147/PPA.S20445. Brett Hauber A, Gonzalez JM, Coombs J, Sirulnik A, Palacios D, Scherzer N. Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST). Patient Prefer Adher. 2011;5:307–14. doi:10.​2147/​PPA.​S20445.
56.
go back to reference Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, et al. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adher. 2013;7:937–49. doi:10.2147/PPA.S43465.CrossRef Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, et al. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adher. 2013;7:937–49. doi:10.​2147/​PPA.​S43465.CrossRef
57.
58.
go back to reference Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013;310(9):918–29. doi:10.1001/jama.2013.277064.CrossRefPubMed Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013;310(9):918–29. doi:10.​1001/​jama.​2013.​277064.CrossRefPubMed
60.
go back to reference Jan S, Usherwood T, Brien JA, Peiris D, Rose J, Hayman N, et al. What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open. 2011;1(2). doi:10.1136/bmjopen-2011-000372. Jan S, Usherwood T, Brien JA, Peiris D, Rose J, Hayman N, et al. What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open. 2011;1(2). doi:10.​1136/​bmjopen-2011-000372.
Metadata
Title
Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data
Authors
Tracey-Lea Laba
Beverley Essue
Merel Kimman
Stephen Jan
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 5/2015
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-014-0099-3

Other articles of this Issue 5/2015

The Patient - Patient-Centered Outcomes Research 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.